Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Michael Halstead currently holds 1,238 shares of Intra-Cellular Therapies, Inc. (ITCI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Michael Halstead has been a net seller of ITCI stock. They have purchased $307.6K and sold $29.8M worth of shares.
Michael Halstead's most recent insider trade was on Nov 13, 2024, when they sold 18,714 shares at $0.00 per share.
Michael Halstead serves as Executive at Intra-Cellular Therapies, Inc. (ITCI). They have executed 125 insider transactions totaling $30.1M over their tenure at the company.
Michael Halstead holds the position of Executive at Intra-Cellular Therapies, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 15 years and currently hold a stake valued at $0.
Michael Halstead has shown a selling trading pattern, with $307.6K in total purchases and $29.8M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Michael Halstead was on Nov 13, 2023, when they sold $2.2M worth of ITCI shares. This transaction involved 41,067 shares at $54.01 per share.
Michael Halstead currently owns 1,238 shares of Intra-Cellular Therapies, Inc. (ITCI), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Michael Halstead's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Michael Halstead has 125 Form 4 filings on record as an insider at Intra-Cellular Therapies, Inc..
Set alerts for Michael Halstead and 40,000+ other insiders.